Wingrove Theresa

Avg. Two Year Performance

No purchase track record
30% Avg. Sale Return
14% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return3%4%22%39%30%
Sale Success Rate2 of 32 of 33 of 32 of 32 of 3

Immunogen Inc.

Drugs » Biotechnology

SVP OF REGULATORY AFFAIRS:

Holdings: 0 shares

Sentiment

Insider Trading Sentiment: Reduce

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--